---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-027885"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2022-10-07T23:59:59+00:00"
generated_at: "2026-06-23T04:39:29.455886+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio shareholders approve reverse stock split (1:10-1:50) and warrant issuance of up to 110.4M shares

## Summary
- Reverse split ratio range 1-for-10 to 1-for-50 approved at Oct 4 special meeting; 45.2M votes for, 2.9M against.
- Issuance of up to 110.4M shares upon exercise of Series 1 and 2 warrants approved at Oct 6 meeting; 5.5M for, 4.0M against.
- Authorized share reduction from 300M to 280M approved at Oct 6 meeting; 11.5M votes for, 1.2M against.
- Reverse split must be effected before 2023 annual meeting; exact ratio set by Board.

## SEC filing metadata
- accession: 0001493152-22-027885
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2022-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315222027885/0001493152-22-027885-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315222027885/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-027885
- JSON: https://secwatch.observer/filing/0001493152-22-027885.json
- Plain text: https://secwatch.observer/filing/0001493152-22-027885.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.